Welcome to our dedicated page for Ascend Wellness news (Ticker: AAWH), a resource for investors and traders seeking the latest updates and insights on Ascend Wellness stock.
Ascend Wellness Holdings reports developments as a multi-state, vertically integrated cannabis operator and consumer packaged goods company. News commonly covers earnings releases, retail and wholesale performance, dispensary openings, and expansion of its regulated cannabis footprint in markets such as Ohio and New Jersey.
Company updates also feature product and brand activity across flower, vapes, edibles, concentrates, gummies, and infused products, including the Ozone, Ozone Reserve, and Simply Herb portfolios. Other recurring themes include supply-chain and social-equity partnerships, operational support for independently operated dispensaries, cost controls, refinancing activity, and the company’s shift toward a CPG-oriented retail model.
Ascend Wellness (CSE: AAWH-U.CN, OTCQX: AAWH) reported Q1 2026 net revenue of $116.9 million, down 3% sequentially, and net loss of $29.5 million. Adjusted EBITDA was $26.3 million with a 22.5% margin; cash stood at $60.9 million.
Adjusted gross margin rose to 46.1%, G&A fell to $42.3 million, and net debt was $241.2 million. The retail footprint reached 51 locations, with 10 more expected by year-end. AWH guides Q2 2026 revenue up 2–3% with Adjusted EBITDA margin in the low-20% range.
Ascend Wellness Holdings (CSE: AAWH-U; OTCQX: AAWH) announced it will hold a first quarter 2026 earnings conference call on Wednesday, May 13, 2026 at 5:00 p.m. ET following release of Q1 2026 results.
Dial-in is 1-888-699-1199, a live audio webcast will be available on the Investor Relations site, and a replay is available until midnight ET on May 20, 2026 (Replay code: 56156#).
Ascend Wellness Holdings (AAWH) opened East Coasting, an independent adult-use dispensary at 178 NJ-35, Eatontown, New Jersey, with a soft opening on April 22, 2026 and a grand opening planned for April 24, 2026.
East Coasting is owned and operated by cannabis reform advocate Kyle Page through a New Jersey partnership that expands investment for diversely owned businesses; Ascend will provide operational support. Store hours are 9 AM–9 PM daily. Ascend highlighted the CO-LAB for Social Equity program supporting restorative justice, mentorship, and funding for diverse entrepreneurs.
Ascend Wellness Holdings (AAWH) and NuProject launched ROOTS, a six-month business readiness program for licensed cannabis operators and ancillary firms in Massachusetts and New Jersey. Applications are open through May 11, 2026. The program offers coaching, technical assistance, mentors, and a demo day for procurement opportunities.
ROOTS targets financial and operational readiness, social equity support, and connections to Ascend's supply chain network.
Ascend Wellness Holdings (CSE: AAWH-U.CN / OTCQX: AAWH) reported Q4 2025 revenue of $120.5M and FY 2025 revenue of $500.6M, with Adjusted EBITDA margin of 25.1% in Q4 and 23.4% for FY 2025. Cash totaled $85.7M at year-end and retail footprint reached 48 locations.
FY 2025 results reflect a 10.9% YoY revenue decline, a net loss of $118.2M, record SKU launches (566), completion of a refinancing and a $17.0M arbitration reserve resolved in Q1 2026.
Ascend Wellness Holdings (AAWH) unveiled a full relaunch of its Ozone flagship brand on March 10, 2026, introducing refreshed visual identity, tightened product standards, new packaging, and expanded SKUs across flower, vapes, concentrates, and gummies.
The roll out begins in Illinois, Massachusetts, and New Jersey, with all seven operating markets to follow, emphasizing higher potency and terpene benchmarks, improved cure protocols, and new full-spectrum and macro-dose gummy offerings.
Ascend Wellness Holdings (AAWH) reported preliminary, unaudited Q4 2025 net revenue of approximately $120 million and FY 2025 net revenue of approximately $500 million, with Adjusted EBITDA of ~$30 million (Q4) and ~$117 million (FY), implying margins near 25% and 23% respectively. The company held ~$86 million cash as of December 31, 2025, notes no significant debt maturities until 2029, disclosed a Feb 5, 2026 arbitration award involving Green Thumb Industries, and scheduled an earnings call for March 12, 2026 at 5:00 PM ET.
Ascend Wellness Holdings (AAWH) opened a new dispensary in Englewood, Ohio at 7701 Hoke Road, serving medical patients and non-medical customers starting January 14, 2026, with a grand opening on January 16, 2026.
The location expands Ascend's Ohio retail footprint alongside stores in Piqua, Cincinnati, Sandusky, Coshocton, and Carroll, offers flower, vapes, edibles, concentrates and Ascend in-house brands, and operates daily from 8:00 a.m.–11:00 p.m.
Ascend Wellness Holdings (OTCQX: AAWH) announced a partnership with Lerone Jones and Mister Jones, LLC to open a retail dispensary at 655 US-46, Little Falls, NJ with a grand opening on December 19, 2025. Ascend will fund the retail space, provide upfront capital, supply its product portfolio, and deliver backend technical and operational support. The partnership is one of the first structured under New Jersey Assembly Bill A4151, which expands investment opportunities for diversely owned cannabis businesses. Mister Jones Dispensary will operate daily from 8:00am to 10:00pm. Ascend highlighted its social equity initiatives, including the CO-LAB for Social Equity, and noted Lerone Jones' prior operational experience and advocacy in New Jersey.
Ascend Wellness Holdings (AAWH) reported Q3 2025 net revenue of $124.7 million and an Adjusted EBITDA of $31.1 million (24.9% margin). Adjusted gross margin expanded by 300 basis points to 46.4%, while GAAP net loss was $25.8 million. Cash totaled $87.3 million and Net Debt was $281.8 million as of September 30, 2025. Operationally, AWH added seven stores year-to-date (46 total) with a pipeline of 13 additional sites targeting ~60 locations in 12 months, launched ~420 SKUs YTD, completed a $9.3 million mortgage financing at 8.5%, and repurchased ~1.0 million shares in Q3.